Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)

BACKGROUND: Several agents provide treatment for established rheumatoid arthritis (RA), but a crucial therapeutic goal is to delay/prevent progression of undifferentiated arthritis (UA) or very early RA. OBJECTIVE: To determine the impact of T-cell costimulation modulation in patients with UA or ver...

Descripción completa

Detalles Bibliográficos
Autores principales: Emery, P, Durez, P, Dougados, M, Legerton, C W, Becker, J-C, Vratsanos, G, Genant, H K, Peterfy, C, Mitra, P, Overfield, S, Qi, K, Westhovens, R
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2009
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927615/
https://www.ncbi.nlm.nih.gov/pubmed/19933744
http://dx.doi.org/10.1136/ard.2009.119016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927615/
https://www.ncbi.nlm.nih.gov/pubmed/19933744
http://dx.doi.org/10.1136/ard.2009.119016

Ejemplares similares